These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2126705)

  • 41. Susceptibility of Enterococcus faecalis to twelve antibiotics, time-kill assays, and high-level aminoglycoside resistance in a university hospital in Argentina.
    Predari SC; Gutiérrez MA; Ribas C; Molinari GS; Santoianni JE
    Rev Argent Microbiol; 1991; 23(2):67-78. PubMed ID: 1815269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [In vitro study of the combination of pefloxacin with other antibiotics against Pseudomonas aeruginosa and Streptococcus group D].
    Zuccarelli M; Attisso MA; Simeon de Buochberg M; Dusart G
    Pathol Biol (Paris); 1987 May; 35(5):581-5. PubMed ID: 3112710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. STUDY OF ANTIBACTERIAL ACTIVITY OF THE PREPARATIONS WITH DIOXIDINE AND LEVOFLOXACIN ON MAIN PURULENT-INFLAMMATORY PROCESSES PATHOGENS.
    Shtaniuk EA; Vovk OO; Krasnikova LV; Polyvianna YI; Kovalenko TI
    Wiad Lek; 2021; 74(9 cz 1):2109-2111. PubMed ID: 34725285
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
    Lascols C; Legrand P; Mérens A; Leclercq R; Muller-Serieys C; Drugeon HB; Kitzis MD; Reverdy ME; Roussel-Delvallez M; Moubareck C; Brémont S; Miara A; Gjoklaj M; Soussy CJ
    Int J Antimicrob Agents; 2011 Mar; 37(3):235-9. PubMed ID: 21295447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical laboratory approach to evaluate efficacy of amikacin. Reevaluation of in vitro MIC break points in disc susceptibility test].
    Uete G; Matsuo K; Uete T
    Jpn J Antibiot; 1992 May; 45(5):489-501. PubMed ID: 1512934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibiotic susceptibility of human gut-derived facultative anaerobic bacteria is different under aerobic versus anaerobic test conditions.
    Kovale L; Nimonkar YS; Green SJ; Shouche YS; Prakash O
    Microbes Infect; 2021; 23(9-10):104847. PubMed ID: 34116163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The in vitro effects of cetyltrimethylammonium naproxenate on oral and pharyngeal microorganisms of various ecological niches.
    Pilloni AP; Buttini G; Giordano B; Iovene MR; di Salvo R; Buommino E; Tufano MA
    J Periodontal Res; 1999 Nov; 34(8):473-7. PubMed ID: 10697804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiation of Kluyvera cryocrescens from Kluyvera ascorbata by irgasan susceptibility testing.
    Altwegg M; Zollinger-Iten J; von Graevenitz A
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):159-68. PubMed ID: 3426156
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial activity and mutagenicity studies of water-soluble phosphazene high polymers.
    Allcock HR; Pucher SR; Fitzpatrick RJ; Rashid K
    Biomaterials; 1992; 13(12):857-62. PubMed ID: 1457679
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria.
    Wilkins TD; Thiel T
    Antimicrob Agents Chemother; 1973 Mar; 3(3):350-6. PubMed ID: 4790595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proposed zone standards for interpretation of fortimicin A disk diffusion tests.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1983 Aug; 18(2):440-2. PubMed ID: 6619294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of anaerobiosis on the activity of fosfomycin trometamol.
    Greenwood D; Brown J; Edwards R
    Infection; 1992; 20 Suppl 4():S305-9. PubMed ID: 1294523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the Oxoid Aura image system for measuring zones of inhibition with the disc diffusion technique.
    Andrews JM; Boswell FJ; Wise R
    J Antimicrob Chemother; 2000 Oct; 46(4):535-40. PubMed ID: 11020249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions.
    Kawahara K; Tsuruda K; Morishita M; Uchida M
    Dent Mater; 2000 Nov; 16(6):452-5. PubMed ID: 10967196
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of a combination of dioxidine with beta-lactam antibiotics in the prevention and treatment of purulent-inflammatory complications].
    Bogomolova NS; Bol'shakov LV; Drachennikova AA
    Antibiot Khimioter; 1990 Nov; 35(11):47-51. PubMed ID: 2128733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of sodium polyanethol sulfonate in the preparation of 5 per cent sheep blood agar plates.
    Wasilauskas BL; Floyd J; Roberts TR
    Appl Microbiol; 1974 Jul; 28(1):91-4. PubMed ID: 4210729
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacokinetics of dioxidine in oncological patients in the postoperative period].
    Ponomareva TR; Malakhova VA; Ana'nev VS
    Antibiot Khimioter; 1989 Sep; 34(9):684-7. PubMed ID: 2692530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of several components of anaerobic incubation on antibiotic susceptibility test results.
    Rosenblatt JE; Schoenknecht F
    Antimicrob Agents Chemother; 1972 May; 1(5):433-40. PubMed ID: 4597114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth of various obligate and facultative anaerobic intestinal bacteria in cell culture medium under aerobic and anaerobic culture conditions.
    Ohkusa T; Koido S; Horiuchi S; Kan S; Ito Z; Nishikawa Y; Sato N
    Biosci Microbiota Food Health; 2022; 41(3):145-148. PubMed ID: 35854697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.